Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 33, Issue 2

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 33, Issue 2 (2024)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 33, Issue 2 (2024)

See all volumes and issues

Volume 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Potential of BGB-11417, a BCL2 inhibitor, in hematological malignancies

Antonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Antonino Neri, Fortunato Morabito, Ernesto Vigna & Massimo Gentile

Pages: 73-77

Published online: 26 Jan 2024

First Page PreviewforPotential of BGB-11417, a BCL2 inhibitor, in hematological malignancies | Full Text | References | PDF (250.5 KB) | EPUB

695 Views
0 CrossRef citations
0Altmetric

Free Access

Drug Evaluation

Review Article

Taletrectinib for the treatment of ROS-1 positive non-small cell lung cancer: a drug evaluation of phase I and II data

Misako Nagasaka, Danielle Brazel & Sai-Hong Ignatius Ou

Pages: 79-84

Published online: 29 Jan 2024

AbstractforTaletrectinib for the treatment of ROS-1 positive non-small cell lung cancer: a drug evaluation of phase I and II data | Full Text | References | PDF (2.7 MB) | EPUB

866 Views
0 CrossRef citations
0Altmetric

Open Access

Special Report

Report

Islatravir: evaluation of clinical development for HIV and HBV

Samuel W. Gillespie, Athreya S. Reddy, Dana M. Burris, S. Hasan Naqvi, Siddappa N. Byrareddy, Christian L. Lorson & Kamal Singh

Pages: 85-93

Published online: 26 Jan 2024

AbstractforIslatravir: evaluation of clinical development for HIV and HBV | Full Text | References | PDF (1.6 MB) | EPUB

179 Views
0 CrossRef citations
0Altmetric

Report

Challenges for further successful development of tumor necrosis factor targeting therapies for uveitis

Zheng Xian Thng, Jonathan Regenold, Albert John Bromeo, Amir Akhavanrezayat, Ngoc T.T. Than, Anadi Khatri, S. Saeed Mohammadi, Anh N.T. Tran, Yong Un Shin, Irmak Karaca, Hashem H. Ghoraba, Christopher Chi Mong Or & Quan Dong Nguyen

Pages: 95-104

Published online: 02 Feb 2024

86 Views
0 CrossRef citations
0Altmetric

Review

Review Article

New investigational drugs to treat Sjogren's syndrome: lessons learnt from immunology

Xingyu Zhou, Dong Xu, Mengtao Li & Xiaofeng Zeng

Pages: 105-114

Published online: 31 Jan 2024

AbstractforNew investigational drugs to treat Sjogren's syndrome: lessons learnt from immunology | Full Text | References | PDF (339 KB) | EPUB

1431 Views
0 CrossRef citations
0Altmetric

Open Access

Review Article

Novel agents to treat adrenal insufficiency: findings of preclinical and early clinical trials

Andrew Peel, R. Louise Rushworth & David J Torpy

Pages: 115-126

Published online: 05 Feb 2024

AbstractforNovel agents to treat adrenal insufficiency: findings of preclinical and early clinical trials | Full Text | References | PDF (353.5 KB) | EPUB

124 Views
0 CrossRef citations
0Altmetric

Review Article

The impact of current investigational drugs for acne on future treatment strategies

Heli A. Patel, Lily Guo & Steven R. Feldman

Pages: 127-132

Published online: 19 Feb 2024

AbstractforThe impact of current investigational drugs for acne on future treatment strategies | Full Text | References | PDF (251.6 KB) | EPUB

117 Views
0 CrossRef citations
0Altmetric

Review Article

Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis

Jacopo Simonetti, Marco Ficili, Giacomo Sgalla & Luca Richeldi

Pages: 133-143

Published online: 01 Feb 2024

AbstractforExperimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis | Full Text | References | PDF (2.3 MB) | EPUB

159 Views
0 CrossRef citations
0Altmetric

Review Article

Progress in the treatment of anal cancer: an overview of the latest investigational drugs

James Yu & Richard D. Kim

Pages: 145-157

Published online: 30 Jan 2024

AbstractforProgress in the treatment of anal cancer: an overview of the latest investigational drugs | Full Text | References | PDF (363.2 KB) | EPUB

96 Views
0 CrossRef citations
0Altmetric

Correction

Page: 159

Published online: 19 Feb 2024

CitationforCorrection | Full Text | PDF (96.5 KB) | EPUB

83 Views
0 CrossRef citations
0Altmetric

Free Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.33, Iss.2, 2024)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?